Amy Wong
Financieel Directeur/CFO bij Apexigen America, Inc.
Oorsprong van het eerstegraads netwerk van Amy Wong
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
| Public Company | Biotechnology | 12 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Amy Wong via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO General Counsel | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Chief Tech/Sci/R&D Officer | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| IMUGENE LIMITED | Biotechnology | Director/Board Member | |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Indiana University | College/University | Doctorate Degree Doctorate Degree | |
| New York University | College/University | Doctorate Degree Graduate Degree | |
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree | |
| Vassar College | College/University | Undergraduate Degree | |
| AMBRX INC | Pharmaceuticals: Major | Consultant / Advisor | |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
| University of Bern | College/University | Doctorate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Comptroller/Controller/Auditor General Counsel | |
| Beijing University of Traditional Chinese Medicine | College/University | Undergraduate Degree | |
Yale Cancer Center
 Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Hospital/Nursing Management | Corporate Officer/Principal | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Weill Cornell Medical College | College/University | Doctorate Degree | |
| Harvard Medical School | College/University | Doctorate Degree | |
| G.D. Searle LLC | Corporate Officer/Principal General Counsel | ||
| The Schulich School of Business | College/University | Masters Business Admin Masters Business Admin | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GOSSAMER BIO, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| INVIVYD, INC. | Biotechnology | Director of Finance/CFO | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 39 |
| Canada | 5 |
| Zwitserland | 3 |
| Verenigd Koninkrijk | 3 |
| Italië | 2 |
Sectoraal
| Health Technology | 32 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Health Services | 3 |
| Retail Trade | 2 |
Operationeel
| Director/Board Member | 91 |
| Corporate Officer/Principal | 48 |
| Director of Finance/CFO | 27 |
| Independent Dir/Board Member | 22 |
| Chairman | 18 |
Sterkste connecties
| Insiders | |
|---|---|
| Daniel Zabrowski | 23 |
| William J. Rutter | 22 |
| Scott Smith | 21 |
| Gordon Ringold | 20 |
| Meenu Chhabra Karson | 17 |
| Sam Wertheimer | 17 |
| Linda Rubinstein | 16 |
| Jakob Dupont | 14 |
| Herbert Cross | 14 |
| William Duke | 11 |
| Kenneth Fong | 11 |
| Meenu Karson | 11 |
| Xiao Dong Yang | 9 |
| Frank Hsu | 9 |
| Francis Sarena | 9 |
